A true, non-invasive blood glucose monitor has the potential to improve the lives of a large proportion of people with diabetes, reducing their suffering and morbidity. The recent collaboration between GlucoRx and Cardiff University, with the excellent technical support of Dr Sam Hefford, has developed a design-to-manufacture, patient-friendly, non-invasive continuous monitor which can generate accurate, real-time measurements of glucose. The presentation will cover the generational development of the device, which interacts with the blood non-invasively via radio-frequency (RF) fields of low power, including previous clinical trials data, leading to the BioXensor we present today. BioXensor incorporates other biometrics such as temperature, activity, SpO2, ECG, respiration and heart rates, to improve the accuracy of glucose readings. Simply attached to the skin on the upper body via adhesive or a band, it will provide early alerts to highlight and prevent hypo- and hyper-glycaemic episodes via Bluetooth communication with a Smart phone. The presentations will review the Bioxensor's underlying RF technology for non-invasive glucose measurement, its chronological development, present previous clinical trials data and discuss next steps for its commercialisation.